
PEARL DIAGNOSTICS, INC.
Diagnostics for Lung Infections
BALTIMORE, United States · Founded 2015 · $8.0M raised
- Headquarters
- BALTIMORE, Maryland
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- pearldx.com
- Total Funding
- $8.0M
- Last Round
- $3.5M SeedJul 2025
- Rounds
- 3
About
Pearl Diagnostics is a Johns Hopkins University spin-off developing in vitro diagnostic assays that detect circulating microbial extracellular vesicles in urine to identify lung infections early and non-invasively. The company received FDA 510(k) clearance for its MycoMEIA Aspergillus Assay in August 2025 and has received investment from CARB-X, the Cystic Fibrosis Foundation, and Johns Hopkins Technology Ventures.
Summary
PEARL DIAGNOSTICS, INC. is a Biotech company based in BALTIMORE, United States, founded in 2015. It has raised $8.0M in total across 3 rounds, most recently a $3.5M Seed round in Jul 2025.
Tech & App Stack
7 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...